Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Arthroscopy ; 28(2): 169-77, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22137238

ABSTRACT

PURPOSE: This study tested a bone-tendon allograft versus human dermis patch for reconstructing chronic rotator cuff repair by use of a canine model. METHODS: Mature research dogs (N = 15) were used. Radiopaque wire was placed in the infraspinatus tendon (IST) before its transection. Three weeks later, radiographs showed IST retraction. Each dog then underwent 1 IST treatment: debridement (D), direct repair of IST to bone with a suture bridge and human dermis patch augmentation (GJ), or bone-tendon allograft (BT) reconstruction. Outcome measures included lameness grading, radiographs, and ultrasonographic assessment. Dogs were killed 6 months after surgery and both shoulders assessed biomechanically and histologically. RESULTS: BT dogs were significantly (P = .01) less lame than the other groups. BT dogs had superior bone-tendon, tendon, and tendon-muscle integrity compared with D and GJ dogs. Biomechanical testing showed that the D group had significantly (P = .05) more elongation than the other groups whereas BT had stiffness and elongation characteristics that most closely matched normal controls. Radiographically, D and GJ dogs showed significantly more retraction than BT dogs (P = .003 and P = .045, respectively) Histologically, GJ dogs had lymphoplasmacytic infiltrates, tendon degeneration and hypocellularity, and poor tendon-bone integration. BT dogs showed complete incorporation of allograft bone into host bone, normal bone-tendon junctions, and well-integrated allograft tendon. CONCLUSIONS: The bone-tendon allograft technique re-establishes a functional IST bone-tendon-muscle unit and maintains integrity of repair in this model. CLINICAL RELEVANCE: Clinical trials using this bone-tendon allograft technique are warranted.


Subject(s)
Biocompatible Materials , Bone Transplantation , Dermis/transplantation , Rotator Cuff Injuries , Rotator Cuff/surgery , Tendons/transplantation , Animals , Biomechanical Phenomena , Dogs , Humans , Orthopedic Procedures/methods , Radiography , Rotator Cuff/diagnostic imaging , Suture Anchors , Transplantation, Homologous
2.
Tissue Eng Part A ; 16(3): 1041-51, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19845465

ABSTRACT

It was hypothesized that previously optimized serum-free culture conditions for juvenile bovine chondrocytes could be adapted to generate engineered cartilage with physiologic mechanical properties in a preclinical, adult canine model. Primary or passaged (using growth factors) adult chondrocytes from three adult dogs were encapsulated in agarose, and cultured in serum-free media with transforming growth factor-beta3. After 28 days in culture, engineered cartilage formed by primary chondrocytes exhibited only small increases in glycosaminoglycan content. However, all passaged chondrocytes on day 28 elaborated a cartilage matrix with compressive properties and glycosaminoglycan content in the range of native adult canine cartilage values. A preliminary biocompatibility study utilizing chondral and osteochondral constructs showed no gross or histological signs of rejection, with all implanted constructs showing excellent integration with surrounding cartilage and subchondral bone. This study demonstrates that adult canine chondrocytes can form a mechanically functional, biocompatible engineered cartilage tissue under optimized culture conditions. The encouraging findings of this work highlight the potential for tissue engineering strategies using adult chondrocytes in the clinical treatment of cartilage defects.


Subject(s)
Aging/metabolism , Cartilage/metabolism , Cell Culture Techniques/methods , Chondrocytes/cytology , Models, Animal , Tissue Engineering , Aging/drug effects , Animals , Biocompatible Materials/pharmacology , Biomechanical Phenomena/drug effects , Cartilage/drug effects , Chondrocytes/drug effects , Chondrocytes/metabolism , Dogs , Extracellular Matrix Proteins/genetics , Extracellular Matrix Proteins/metabolism , Gene Expression Regulation/drug effects , Hindlimb/drug effects , Hindlimb/pathology , Hindlimb/surgery , Implants, Experimental , Synovial Membrane/drug effects , Synovial Membrane/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...